Oxford

The Oxford adenovirus COVID-19 vaccine is safe and elicits significant immune responses in study volunteers, according to research published in The Lancet.Share on PinterestWill the Oxford vaccine turn the tide of the pandemic?Image credit: Steve Parsons / POOL / AFPAmong the myriad of vaccine candidates that researchers across the globe are developing to stop the…

Promising results from trials of three potential coronavirus vaccines have raised hopes in the fight against the COVID-19 pandemic, which has killed more than 600,000 people and crushed economies globally. Early-stage clinical trials of AZD1222, a closely-watched experimental vaccine being developed by AstraZeneca and scientists at Oxford University in the United Kingdom, induced "robust immune…

A senior British official has called the latest news on an Oxford University team's potential coronavirus vaccine "extremely encouraging." The results of the Phase I/II trial of the vaccine being developed by Oxford's Jenner Institute, in conjunction with pharmaceutical giant AstraZeneca, showed that it is safe and "produced strong immune results," according to the research…

COVID-19 vaccine trial shows promising results COVID-19 vaccine trial shows promising result... 03:29 A senior British official has called the latest news on an Oxford University team's potential coronavirus vaccine "extremely encouraging." The results of the Phase I/II trial of the vaccine being developed by Oxford's Jenner Institute, in conjunction with pharmaceutical giant AstraZeneca, showed…

The coronavirus pandemic is still rapidly spreading across the globe, infecting more than 14.44 million people. With more than 188 countries and territories affected, scientists are racing to develop a vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19). One of the forerunners in this vaccine…